PERISTALTIC DISSOLUTION APPARATUS: UTILITY IN NEW DOSAGE FORM DESIGNSIMMONS DL; LEGORE AA; PICOTTE P et al.1980; CAN. J. PHARM. SCI.; ISSN 0008-4190; CAN; DA. 1980; VOL. 15; NO 2; PP. 26-29; BIBL. 9 REF.Article

A DISSOLUTION RATE APPARATUS FOR THE PREDICTION OF INITIAL DRUG ABSORPTION PATTERNS IN BEAGLES : TOLBUTAMIDE TABLETSSIMMONS DL; LEGORE AA; PICOTTE P et al.1975; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1975; VOL. 3; NO 1; PP. 39-49; BIBL. 2REF.Article

POLYMORPHISM IN PHARMACEUTICALS. II. TOLBUTAMIDESIMMONS DL; RANZ RJ; GYANCHANDANI ND et al.1972; CANAD. J. PHARM. SCI.; CANADA; DA. 1972; VOL. 7; NO 4; PP. 121-123; ABS. FR.; BIBL. 2REF.Serial Issue

The use of vitreous humor levels of glucose, lactic acid and blood levels of acetone to establish antemortem hyperglycemia in diabeticsPECLET, C; PICOTTE, P; JOBIN, F et al.Forensic science international. 1994, Vol 65, Num 1, pp 1-6, issn 0379-0738Article